Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-16 | 27.0 | 65 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | IL-16 | 42.0 | 60 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-16 | 145.0 | 66 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | IL-16 | 27.0 | 57 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-16 | 42.0 | 47 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | IL-16 | 28.0 | 52 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-16 | 109.0 | 47 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-16 | 29.0 | 65 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | IL-16 | 27.0 | 55 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-16 | 269.0 | 44 | |
N2759 | TNF-a | 100 | ng/mL | 3 | IL-16 | 234.0 | 53 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-16 | 57.0 | 44 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | IL-16 | 59.5 | 50 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-16 | 129.0 | 49 | |
N2586 | TNF-a | 100 | ng/mL | 3 | IL-16 | 172.0 | 51 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-16 | 17.0 | 50 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | IL-16 | 16.5 | 62 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-16 | 50.0 | 51 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | IL-16 | 54.0 | 79 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-16 | 20.0 | 51 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | IL-16 | 21.0 | 55 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-16 | 26.0 | 61 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | IL-16 | 27.0 | 50 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | IL-16 | 14.5 | 60 | ||||
RA1869 | 3 | IL-16 | 16.5 | 64 |